NSE filing, NSE: INDSWFTLAB. Summary written from the filing by ALFA Finder's alert engine.
Ind-Swift Laboratories Ltd: key numbers
- Share price
- ₹350.90
- Market cap
- ₹3,051 Cr
- Revenue (annual)
- ₹649.1 Cr
- Net profit (annual)
- ₹43.12 Cr
- P/E (TTM)
- 36.5×Sector 47.2×
- Promoter holding
- 42.93%+0.00% QoQ
- FII holding
- 10.78%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ind-Swift Laboratories Ltd
All →Ind-Swift Laboratories Convertible Warrants
Ind-Swift Laboratories has fully utilized the Rs. 314.60 Crore proceeds from its preferential issue of convertible warrants. The monitoring agency CARE Ratings confirms no deviations in fund usage.
- Value
- ₹314.6 Cr
Ind-Swift Laboratories Results Update
Ind-Swift Laboratories reported Q2 FY27 revenue up 50% to ₹234.89 crore and PAT up 3.5x to ₹31.03 crore. Operating EBITDA margin rose to 18.02%.
Ind-Swift Laboratories Q2 FY27 Results: Net Profit ₹34.2 Cr, Up 327.5% YoY
Ind-Swift Laboratories Ltd reported revenue from operations of ₹240.5 Cr (+51.6% YoY) and net profit of ₹34.2 Cr (+327.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹34.2 Cr · +327.5% YoY
Ind-Swift Laboratories Board Meeting Date
Ind-Swift Laboratories Ltd. scheduled a board meeting for October 29, 2026, to consider and approve the standalone and consolidated financial results for the quarter and half-year.
Ind-Swift Laboratories Convertible Warrants
Essix Biosciences Limited acquired 14,00,000 equity shares of Ind-Swift Laboratories Limited following the conversion of fully convertible warrants. The company disclosed this under SEBI regulations.
Ind-Swift Laboratories Capital Structure Change
Ind-Swift Laboratories allotted 14,00,000 equity shares upon conversion of warrants at Rs. 196 each. The allotment follows a previously approved preferential issue.
- Value
- ₹27.44 Cr
Other other announcement announcements
All →Birla Cotsyn (India) Other Announcement
Birla Cotsyn (India) Ltd filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter holding is 94.58% while public holding is 5.42%, below the 25% minimum public shareholding requirement.
Aravali Securities & Finance Other Announcement
Aravali Securities & Finance filed its quarterly shareholding pattern for the period ended 30-Sep-2026 under Regulation 31(1)(b). It is a routine periodic disclosure with no transaction or money involved.
Solar Industries India Other Announcement
Solar Industries India appointed Price Waterhouse LLP as joint statutory auditor and re-appointed Gandhi Rathi & Co for five years from the 32nd AGM. This replaces retiring auditor SRBC & Co LLP, which continues until that AGM.
- Execution
- Five years, from the conclusion of the 32nd AGM (2027) until the conclusion of the 37th AGM (2032)
Mahindra & Mahindra Other Announcement
Mahindra & Mahindra intimated that its RTA, KFin Technologies, is shifting its corporate office to a new Kokapet, Hyderabad address from 1 December 2026. The registered office is unchanged.
Sigma Solve Other Announcement
Sigma Solve reported its Regulation 32 IPO fund-utilisation statement for the quarter ended September 30, 2026. It shows no deviation in utilised amounts, with Rs.31.57 lakh of unutilised public issue expenses moved to General Corporate Purpose.
RO Jewels Other Announcement
RO Jewels Ltd has filed its quarterly shareholding pattern for the period ended 30 September 2026 under Regulation 31. The filing shows promoter and promoter group holdings of about 99.4 percent and records no transaction or money amount.